Here Is Why These Four Stocks Stand Out from the Crowd on Tuesday

We will now take a thorough look at what stands behind the surge of another healthcare-related stock. Shares of specialty pharmaceutical company SciClone Pharmaceuticals Inc. (NASDAQ:SCLN) are 29% in the green so far today, following the release of its third-quarter financial results. The company’s revenues increased to $42.9 million from $34.3 million year-on-year, while its non-GAAP diluted earnings per share climbed to $0.26 from $0.17.  Even though industry analysts have previously claimed that the Chinese pharmaceuticals market was set to experience lower growth rates relative to 2014, SciClone Pharmaceuticals Inc. (NASDAQ:SCLN)’s management still anticipates a robust growth rate of 9-10% in 2015. The company also raised its full-year non-GAAP earnings guidance to the range of $0.93-to-$0.97, up from the previously-anticipated range of $0.73-to-$0.77. Meanwhile, its revenue guidance stays put at $153 million-to-$158 million. The number of hedge funds with positions in the company at the end of the second quarter stood at 20, compared to 16 registered in the prior quarter. From the pool of over 700 hedge funds observed by Insider Monkey, Cliff Asness’ AQR Capital Management was among the largest equity holders of SciClone Pharmaceuticals Inc. (NASDAQ:SCLN) on June 30, holding nearly 559,000 shares.

It appears that Atwood Oceanics Inc. (NYSE:ATW)’s shares have also surged on the back of stronger-than-expected financial figures, gaining over 12% so far in today’s trading session. The offshore drilling contractor reported fourth fiscal quarter net earnings per share (EPS) of $2.32 on revenues of $363.2 million, compared to EPS of $1.72 on revenues of $323.4 million reported for the same period of last year. Just a few hours ago, Atwood Oceanics Inc. (NYSE:ATW) announced that one of its subsidiaries sealed an extension and rate adjustment agreement in relation to its existing contract with Noble Energy Inc. (NYSE:NBL) for its ultra-deepwater rig Atwood Advantage. This agreement is made in connection with the plugging and abandoning four well program in the Gulf of Mexico. Meanwhile, the stock is trading at a really attractive level if solely looking at its trailing P/E ratio of only 2.80, which compares to the median of 23.41 for the S&P 500 companies. 25 hedge funds tracked by our team had positions in the company at the end of the second quarter, accumulating 14.20% of its outstanding shares. David Dreman’s Dreman Value Management added a 274,778-share position in Atwood Oceanics Inc. (NYSE:ATW) to its portfolio during the June quarter.

Disclosure: None